Clinical Characteristics and Outcomes of Coronary Heart D... | NCT06335901

Studies
Clinical Characteristics and Outcomes of Coronary Heart Disease

NCT06335901

Sponsor

Xinjiang Medical University

Status

Completed

Last Update Posted

Apr 17, 2025Actual

Enrollment

20,000Actual

Phase

Not provided

Conditions

Coronary Heart Disease

Interventions

Drug:Standard therapy

Countries

China

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

Apr 2025

Overall Recruitment Status or Expanded Access Status

Completed

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Feb 1, 2020Actual

Primary Completion Date

Jan 31, 2022Actual

Completion Date

Apr 30, 2022Actual

First Submitted Date

Mar 22, 2024

First Submission Date that Met QC Criteria

Mar 22, 2024

First Posted Date

Mar 28, 2024Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

Apr 14, 2025

Last Update Posted Date

Apr 17, 2025Actual

Sponsor/Collaborators Module

Responsible Party, by Official Title

Xiang Xie, Xiangxie, MD,The First Affiliated Hospital Of XinJiang Medicial University, Xinjiang Medical UniversityPrincipal Investigator

Lead Sponsor

Xinjiang Medical UniversityOTHER

Collaborators

Not provided

Oversight Module

Has Data Monitoring Committee (DMC)

Yes

Is FDA Regulated Drug

Not provided

Is FDA Regulated Device

Not provided

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

This study evaluated and compared the prognostic value of different Baseline data and clinical variables to develop predictive model in patients with CHD.

Detailed Description

Not provided

Design Module

Study Type

Observational

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Target Follow-Up Duration

Not provided

Phases

Not provided

Interventional Study Design

Allocation

Not provided

Intervention Model

Biospecimen

No data available

No data is available for this block.

Enrollment

20,000Actual

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
2			Drug: Drug:Standard therapy

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Drug:Standard therapy	Drug	Percutaneous coronary Intervention	2

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Death （All-cause mortality、Cardiac mortality ）		5 years of follow-up deaths occurred during this period

Secondary Outcomes

Measure	Description	Time Frame
Major adverse cardiovascular events		5 years of follow-up deaths occurred during this period

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Patients diagnosed with Coronary Heart Disease (CHD) admitted to the First Affiliated Hospital of Xinjiang Medical University.
The diagnosis is based on clinical assessments, including symptomatic evaluation, electrocardiographic findings, and coronary angiography.

Exclusion Criteria:

We excluded patients who had serious heart failure, malignant tumor，rheumatic heart disease, valvular heart disease, congenital heart disease, pulmonary heart disease and serious dysfunction of the liver or kidney.

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

79 Years

Standard Ages

AdultOlder Adult

Study Population

Patients with coronary heart disease hospitalized at the First Affiliated Hospital of Xinjiang Medical University.

Sampling Method

Probability Sample

Contacts/Locations Module

Central Contacts

Not provided

Overall Officials

Not provided

Locations

Facility	Status	City	State	ZIP	Country	Contacts
The First Affiliated Hospital of Xinjiang Medical University		Ürümqi	Xinjiang	630000	China

IPD Sharing Statement Module

Plan to Share IPD

Description

Not provided

Types

Not provided

Time Frame

Not provided

Access Criteria

Not provided

URL

Not provided

Condition Browse Module

MeSH Terms

ID	Term
D003327	Coronary Disease

Ancestor Terms

ID	Term
D017202	Myocardial Ischemia
D006331	Heart Diseases
D002318	Cardiovascular Diseases
D014652	Vascular Diseases

Browse Leaves

Not provided

Browse Branches

Not provided